Treg cells have the ability to limit the function of antigen-presenting cells by CTLA-4-dependent downregulation of CD80 and CD86, thereby playing a detrimental role in suppressing cancer progression by evading immune surveillance and suppressing the antitumor immune response54,55. The gene discussed is CD86; the disease is cancer.